
### [NCIT:C9312](http://purl.obolibrary.org/obo/NCIT_C9312)
**Label:** Bone Sarcoma

**Subclasses:** [NCIT:C4834](http://purl.obolibrary.org/obo/NCIT_C4834) (Primary Bone Osteosarcoma), [NCIT:C115998](http://purl.obolibrary.org/obo/NCIT_C115998) (Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone), [NCIT:C4835](http://purl.obolibrary.org/obo/NCIT_C4835) (Ewing Sarcoma of Bone), [NCIT:C115997](http://purl.obolibrary.org/obo/NCIT_C115997) (Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone), [NCIT:C6612](http://purl.obolibrary.org/obo/NCIT_C6612) (Stage III Osteosarcoma  AJCC v7), [NCIT:C114782](http://purl.obolibrary.org/obo/NCIT_C114782) (Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone), [NCIT:C115351](http://purl.obolibrary.org/obo/NCIT_C115351) (Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone), [NCIT:C35870](http://purl.obolibrary.org/obo/NCIT_C35870) (Conventional Osteosarcoma), [NCIT:C53706](http://purl.obolibrary.org/obo/NCIT_C53706) (Radiation-Related Osteosarcoma), [NCIT:C53707](http://purl.obolibrary.org/obo/NCIT_C53707) (Bone Osteosarcoma), [NCIT:C53704](http://purl.obolibrary.org/obo/NCIT_C53704) (Secondary Osteosarcoma), [NCIT:C6705](http://purl.obolibrary.org/obo/NCIT_C6705) (Stage II Bone Sarcoma  AJCC v7), [NCIT:C6704](http://purl.obolibrary.org/obo/NCIT_C6704) (Stage I Bone Sarcoma  AJCC v7), [NCIT:C8969](http://purl.obolibrary.org/obo/NCIT_C8969) (Parosteal Osteosarcoma), [NCIT:C6589](http://purl.obolibrary.org/obo/NCIT_C6589) (Childhood Parosteal Osteosarcoma), [NCIT:C6468](http://purl.obolibrary.org/obo/NCIT_C6468) (Stage III Bone Sarcoma  AJCC v7), [NCIT:C6622](http://purl.obolibrary.org/obo/NCIT_C6622) (Recurrent Bone Ewing Sarcoma), [NCIT:C6621](http://purl.obolibrary.org/obo/NCIT_C6621) (Metastatic Bone Ewing Sarcoma), [NCIT:C27482](http://purl.obolibrary.org/obo/NCIT_C27482) (Secondary Chondrosarcoma), [NCIT:C115368](http://purl.obolibrary.org/obo/NCIT_C115368) (Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone), [NCIT:C6701](http://purl.obolibrary.org/obo/NCIT_C6701) (Stage IV Osteosarcoma  AJCC v7), [NCIT:C6469](http://purl.obolibrary.org/obo/NCIT_C6469) (Osteosarcoma Arising in Paget Disease of Bone), [NCIT:C6623](http://purl.obolibrary.org/obo/NCIT_C6623) (Localized Bone Ewing Sarcoma), [NCIT:C114750](http://purl.obolibrary.org/obo/NCIT_C114750) (Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone), [NCIT:C7357](http://purl.obolibrary.org/obo/NCIT_C7357) (Periosteal Chondrosarcoma), [NCIT:C7598](http://purl.obolibrary.org/obo/NCIT_C7598) (Bone Liposarcoma), [NCIT:C8563](http://purl.obolibrary.org/obo/NCIT_C8563) (Undifferentiated High Grade Pleomorphic Sarcoma of Bone), [NCIT:C7155](http://purl.obolibrary.org/obo/NCIT_C7155) (Primary Central Chondrosarcoma), [NCIT:C7154](http://purl.obolibrary.org/obo/NCIT_C7154) (Bone Leiomyosarcoma), [NCIT:C121881](http://purl.obolibrary.org/obo/NCIT_C121881) (Secondary Central Chondrosarcoma), [NCIT:C6590](http://purl.obolibrary.org/obo/NCIT_C6590) (Childhood Conventional Osteosarcoma), [NCIT:C53958](http://purl.obolibrary.org/obo/NCIT_C53958) (High Grade Surface Osteosarcoma), [NCIT:C6706](http://purl.obolibrary.org/obo/NCIT_C6706) (Stage IV Bone Sarcoma  AJCC v7), [NCIT:C53953](http://purl.obolibrary.org/obo/NCIT_C53953) (Osteoblastic Osteosarcoma), [NCIT:C6709](http://purl.obolibrary.org/obo/NCIT_C6709) (Stage I Osteosarcoma  AJCC v7), [NCIT:C6479](http://purl.obolibrary.org/obo/NCIT_C6479) (Bone Angiosarcoma), [NCIT:C6710](http://purl.obolibrary.org/obo/NCIT_C6710) (Stage II Osteosarcoma  AJCC v7), [NCIT:C136632](http://purl.obolibrary.org/obo/NCIT_C136632) (Bone Sarcoma by AJCC v7 Stage), [NCIT:C136633](http://purl.obolibrary.org/obo/NCIT_C136633) (Osteosarcoma by AJCC v7 Stage), [NCIT:C6475](http://purl.obolibrary.org/obo/NCIT_C6475) (Clear Cell Chondrosarcoma), [NCIT:C6476](http://purl.obolibrary.org/obo/NCIT_C6476) (Dedifferentiated Chondrosarcoma), [NCIT:C6470](http://purl.obolibrary.org/obo/NCIT_C6470) (Multifocal Osteosarcoma), [NCIT:C8970](http://purl.obolibrary.org/obo/NCIT_C8970) (Periosteal Osteosarcoma), [NCIT:C123398](http://purl.obolibrary.org/obo/NCIT_C123398) (Childhood Periosteal Osteosarcoma), [NCIT:C6604](http://purl.obolibrary.org/obo/NCIT_C6604) (Bone Fibrosarcoma), [NCIT:C4304](http://purl.obolibrary.org/obo/NCIT_C4304) (Malignancy in Giant Cell Tumor of Bone), [NCIT:C4021](http://purl.obolibrary.org/obo/NCIT_C4021) (Chondroblastic Osteosarcoma), [NCIT:C53493](http://purl.obolibrary.org/obo/NCIT_C53493) (Mesenchymal Chondrosarcoma of Bone), [NCIT:C7134](http://purl.obolibrary.org/obo/NCIT_C7134) (Bone Surface (Peripheral) Osteosarcoma), [NCIT:C4020](http://purl.obolibrary.org/obo/NCIT_C4020) (Fibroblastic Osteosarcoma), [NCIT:C38157](http://purl.obolibrary.org/obo/NCIT_C38157) (Metachronous Osteosarcoma), 

**Class expressions from DL-Learner:**

- Thing 52.66%
- [NCIT:C12964](http://purl.obolibrary.org/obo/NCIT_C12964) (Connective and Soft Tissue) 40.71%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36695](http://purl.obolibrary.org/obo/NCIT_C36695) (LKB1 Gene Inactivation))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36693](http://purl.obolibrary.org/obo/NCIT_C36693) (SMAD4/DPC4 Gene Inactivation))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36692](http://purl.obolibrary.org/obo/NCIT_C36692) (PTEN Gene Inactivation))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36691](http://purl.obolibrary.org/obo/NCIT_C36691) (PTCH Gene Inactivation))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36690](http://purl.obolibrary.org/obo/NCIT_C36690) (MEN1 Gene Inactivation))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36689](http://purl.obolibrary.org/obo/NCIT_C36689) (BRCA2 Gene Inactivation))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36688](http://purl.obolibrary.org/obo/NCIT_C36688) (BRCA1 Gene Inactivation))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36687](http://purl.obolibrary.org/obo/NCIT_C36687) (VHL Gene Inactivation))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36686](http://purl.obolibrary.org/obo/NCIT_C36686) (NF2 Gene Inactivation))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36685](http://purl.obolibrary.org/obo/NCIT_C36685) (NF1 Gene Inactivation))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36684](http://purl.obolibrary.org/obo/NCIT_C36684) (WT1 Gene Inactivation))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36683](http://purl.obolibrary.org/obo/NCIT_C36683) (APC Gene Inactivation))) 39.90%


